424 related articles for article (PubMed ID: 28358282)
1. Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial.
Puviani M; Galloni C; Marchetti S; Sergio Pavone P; Lovati S; Pistone G; Caputo V; Tilotta G; Scarcella G; Campione E; Diluvio L; Garofalo V; Bianchi L; Milani M
Curr Med Res Opin; 2017 Jul; 33(7):1255-1259. PubMed ID: 28358282
[TBL] [Abstract][Full Text] [Related]
2. Effects of topical piroxicam and sun filters in actinic keratosis evolution and field cancerization: a two-center, assessor-blinded, clinical, confocal microscopy and dermoscopy evaluation trial.
Agozzino M; Russo T; Franceschini C; Mazzilli S; Garofalo V; Campione E; Bianchi L; Milani M; Argenziano G
Curr Med Res Opin; 2019 Oct; 35(10):1785-1792. PubMed ID: 31148490
[No Abstract] [Full Text] [Related]
3. Efficacy of different photoprotection strategies in preventing actinic keratosis new lesions after photodynamic therapy. The ATHENA study: a two-center, randomized, prospective, assessor-blinded pragmatic trial.
Pavone PS; Lovati S; Scarcella G; Milani M
Curr Med Res Opin; 2019 Jan; 35(1):141-145. PubMed ID: 30404544
[No Abstract] [Full Text] [Related]
4. Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study.
Babino G; Diluvio L; Bianchi L; Orlandi A; Di Prete M; Chimenti S; Milani M; Campione E
Curr Med Res Opin; 2016 Aug; 32(8):1345-9. PubMed ID: 27046744
[TBL] [Abstract][Full Text] [Related]
5. Effects of topical 0.8% piroxicam and 50+ sunscreen filters on actinic keratosis in hypertensive patients treated with or without photosensitizing diuretic drugs: an observational cohort study.
Mazzilli S; Garofalo V; Ventura A; Diluvio L; Milani M; Bianchi L; Campione E
Clin Cosmet Investig Dermatol; 2018; 11():485-490. PubMed ID: 30349346
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Grade II and III Actinic Keratosis Lesions with a Film-Forming Medical Device Containing Sunscreen/Piroxicam 0.8% and a Retinoic Acid/Glycolic Gel: A Pilot Trial.
Puviani M; Milani M
Dermatol Ther (Heidelb); 2018 Sep; 8(3):399-404. PubMed ID: 29855896
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a photolyase-based device in the treatment of cancerization field in patients with actinic keratosis and non-melanoma skin cancer.
Puviani M; Barcella A; Milani M
G Ital Dermatol Venereol; 2013 Dec; 148(6):693-8. PubMed ID: 24442053
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Multiple Actinic Keratosis and Field of Cancerization with Topical Piroxicam 0.8% and Sunscreen 50+ in Organ Transplant Recipients: A Series of 10 Cases.
Garofalo V; Ventura A; Mazzilli S; Diluvio L; Bianchi L; Toti L; Tisone G; Milani M; Campione E
Case Rep Dermatol; 2017; 9(3):211-216. PubMed ID: 29282394
[TBL] [Abstract][Full Text] [Related]
9. Fluorescent photodiagnostic evaluation of field cancerization treated with a medical device containing piroxicam 0.8% and sunscreen SPF 50+ for actinic keratosis.
Bobyr I; Campanati A; Giacchetti A; Offidani A
Photodermatol Photoimmunol Photomed; 2019 Jul; 35(4):277-279. PubMed ID: 30690758
[No Abstract] [Full Text] [Related]
10. Efficacy of a Film-Forming Medical Device Containing Piroxicam and Sun Filters in the Treatment of Multiple Actinic Keratosis Lesions in a Subject with a History of Kaposi Sarcoma.
Scotti E; Deledda S; Milani M
Case Rep Dermatol; 2016; 8(3):254-261. PubMed ID: 28101017
[TBL] [Abstract][Full Text] [Related]
11. Topical treatment of actinic keratoses with piroxicam 1% gel: a preliminary open-label study utilizing a new clinical score.
Campione E; Diluvio L; Paternò EJ; Chimenti S
Am J Clin Dermatol; 2010; 11(1):45-50. PubMed ID: 20000874
[TBL] [Abstract][Full Text] [Related]
12. Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze).
Nelson C; Rigel D; Smith S; Swanson N; Wolf J
J Drugs Dermatol; 2004; 3(4):401-7. PubMed ID: 15303784
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of lidocaine 7 %, tetracaine 7 % self-occlusive cream in reducing MAL-cPDT-associated pain in subjects with actinic keratosis: A randomized, single-blind, vehicle-controlled trial (The "3P-Trial").
Brumana MB; Milani M; Puviani M
Photodiagnosis Photodyn Ther; 2020 Jun; 30():101758. PubMed ID: 32294560
[TBL] [Abstract][Full Text] [Related]
14. A 9-month, randomized, assessor-blinded, parallel-group study to evaluate clinical effects of film-forming medical devices containing photolyase and sun filters in the treatment of field cancerization compared with sunscreen in patients after successful photodynamic therapy for actinic keratosis.
Eibenschutz L; Silipo V; De Simone P; Buccini PL; Ferrari A; Carbone A; Catricalà C
Br J Dermatol; 2016 Dec; 175(6):1391-1393. PubMed ID: 27167413
[No Abstract] [Full Text] [Related]
15. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.
Ulrich C; Johannsen A; Röwert-Huber J; Ulrich M; Sterry W; Stockfleth E
Eur J Dermatol; 2010; 20(4):482-8. PubMed ID: 20507841
[TBL] [Abstract][Full Text] [Related]
16. Dermoscopy and methyl aminolevulinate: A study for detection and evaluation of field cancerization.
Rossi A; Garelli V; Pranteda G; Cardone M; Anzalone A; Fortuna MC; Di Nunno D; Mari E; De Vita G; Carlesimo M
J Photochem Photobiol B; 2016 Sep; 162():72-76. PubMed ID: 27344021
[TBL] [Abstract][Full Text] [Related]
17. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3 multicenter, randomized, double-blind, placebo-controlled studies.
Swanson N; Smith CC; Kaur M; Goldenberg G
J Drugs Dermatol; 2013 Nov; 12(11):1278-82. PubMed ID: 24196337
[TBL] [Abstract][Full Text] [Related]
18. Topical corticosteroid has no influence on inflammation or efficacy after ingenol mebutate treatment of grade I to III actinic keratoses (AK): A randomized clinical trial.
Erlendsson AM; Karmisholt KE; Haak CS; Stender IM; Haedersdal M
J Am Acad Dermatol; 2016 Apr; 74(4):709-15. PubMed ID: 26810403
[TBL] [Abstract][Full Text] [Related]
19. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
Swanson N; Smith CC; Kaur M; Goldenberg G
J Drugs Dermatol; 2014 Feb; 13(2):166-9. PubMed ID: 24509967
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of sunscreen with photolyase or regular sunscreen associated with topical antioxidants in treating advanced photodamage and cutaneous field cancerization: a randomized clinical trial.
Alvares BA; Miola AC; Schimitt JV; Miot HA; Abbade LPF
An Bras Dermatol; 2022; 97(2):157-165. PubMed ID: 35039206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
